In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines.

Di Cesare S, Marshall JC, Fernandes BF, Logan P, Antecka E, Filho VB, Burnier MN Jr.

Cancer Cell Int. 2007 Nov 14;7:17.

PMID: 18001467 [PubMed - in process]

Related Articles Free article in PMC

CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer.

Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K, Masui T, Fujimoto K, Tamamura H, Hiramatsu K, Fujii N, Imamura M.

Mol Cancer Ther. 2004 Jan;3(1):29-37.

PMID: 14749473 [PubMed - indexed for MEDLINE]

Related Articles

The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.

Arya M, Patel HR, McGurk C, Tatoud R, Klocker H, Masters J, Williamson M.

J Exp Ther Oncol. 2004 Dec;4(4):291-303.

PMID: 15844659 [PubMed - indexed for MEDLINE]

Related Articles

CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.

Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, Kucia M, Marquez L, Peiper SC, Barr FG, Janowska-Wieczorek A, Ratajczak MZ.

Blood. 2002 Oct 1;100(7):2597-606.

PMID: 12239174 [PubMed - indexed for MEDLINE]

Related Articles

Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.

Hatse S, Princen K, Liekens S, Vermeire K, De Clercq E, Schols D.

Cytometry A. 2004 Oct;61(2):178-88.

PMID: 15382150 [PubMed - indexed for MEDLINE]

Related Articles

CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.

Vaday GG, Hua SB, Peehl DM, Pauling MH, Lin YH, Zhu L, Lawrence DM, Foda HD, Zucker S.

Clin Cancer Res. 2004 Aug 15;10(16):5630-9.

PMID: 15328206 [PubMed - indexed for MEDLINE]

Related Articles

Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.

Burger M, Hartmann T, Krome M, Rawluk J, Tamamura H, Fujii N, Kipps TJ, Burger JA.

Blood. 2005 Sep 1;106(5):1824-30. Epub 2005 May 19.

PMID: 15905192 [PubMed - indexed for MEDLINE]

Related Articles

Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.

Fukuda S, Broxmeyer HE, Pelus LM.

Blood. 2005 Apr 15;105(8):3117-26. Epub 2004 Dec 23.

PMID: 15618475 [PubMed - indexed for MEDLINE]

Related Articles

Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry.

Princen K, Hatse S, Vermeire K, De Clercq E, Schols D.

Cytometry A. 2003 Jan;51(1):35-45.

PMID: 12500303 [PubMed - indexed for MEDLINE]

Related Articles

Role of CXCL12 in metastasis of human ovarian cancer.

Jiang YP, Wu XH, Xing HY, DU XY.

Chin Med J (Engl). 2007 Jul 20;120(14):1251-5.

PMID: 17697577 [PubMed - indexed for MEDLINE]

Related Articles

Human melanoma metastases express functional CXCR4.

Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G.

Clin Cancer Res. 2006 Apr 15;12(8):2427-33.

PMID: 16638848 [PubMed - indexed for MEDLINE]

Related Articles

Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.

Shibuta K, Mori M, Shimoda K, Inoue H, Mitra P, Barnard GF.

Jpn J Cancer Res. 2002 Jul;93(7):789-97.

PMID: 12149145 [PubMed - indexed for MEDLINE]

Related Articles

Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.

Mochizuki H, Matsubara A, Teishima J, Mutaguchi K, Yasumoto H, Dahiya R, Usui T, Kamiya K.

Biochem Biophys Res Commun. 2004 Jul 30;320(3):656-63.

PMID: 15240098 [PubMed - indexed for MEDLINE]

Related Articles

Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4.

Signoret N, Oldridge J, Pelchen-Matthews A, Klasse PJ, Tran T, Brass LF, Rosenkilde MM, Schwartz TW, Holmes W, Dallas W, Luther MA, Wells TN, Hoxie JA, Marsh M.

J Cell Biol. 1997 Nov 3;139(3):651-64.

PMID: 9348282 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.

Chen X, Beutler JA, McCloud TG, Loehfelm A, Yang L, Dong HF, Chertov OY, Salcedo R, Oppenheim JJ, Howard OM.

Clin Cancer Res. 2003 Aug 1;9(8):3115-23.

PMID: 12912963 [PubMed - indexed for MEDLINE]

Related Articles

CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.

Cardones AR, Murakami T, Hwang ST.

Cancer Res. 2003 Oct 15;63(20):6751-7.

PMID: 14583470 [PubMed - indexed for MEDLINE]

Related Articles

CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.

Hwang JH, Hwang JH, Chung HK, Kim DW, Hwang ES, Suh JM, Kim H, You KH, Kwon OY, Ro HK, Jo DY, Shong M.

J Clin Endocrinol Metab. 2003 Jan;88(1):408-16.

PMID: 12519884 [PubMed - indexed for MEDLINE]

Related Articles

The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells.

Kijowski J, Baj-Krzyworzeka M, Majka M, Reca R, Marquez LA, Christofidou-Solomidou M, Janowska-Wieczorek A, Ratajczak MZ.

Stem Cells. 2001;19(5):453-66.

PMID: 11553854 [PubMed - indexed for MEDLINE]

Related Articles

Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.

Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A, Allavena P.

Cancer Res. 2004 Nov 15;64(22):8420-7.

PMID: 15548713 [PubMed - indexed for MEDLINE]

Related Articles

Follicular dendritic cell regulation of CXCR4-mediated germinal center CD4 T cell migration.

Estes JD, Thacker TC, Hampton DL, Kell SA, Keele BF, Palenske EA, Druey KM, Burton GF.

J Immunol. 2004 Nov 15;173(10):6169-78.

PMID: 15528354 [PubMed - indexed for MEDLINE]

Related Articles